"Star of Life", emergency medical care symbol : background, specifications, and criteria.

Mode of access: Internet.

Family expenditures for medical care, five regions,

Made-up set; supplied title.

Directory of prepayment medical care service plans [open to participation by organized labor groups]

"Issued under the auspices of the Cooperative Health Federation of America and the Committee for the Nation's Health."

Voluntary health insurance and medical care; five years of progress, 1952-1957,

Cover title.

Legal aspects of PHS medical care : a programmed instruction course.

Based on, and companion to the Author's Legal aspects of PHS medical care teaching frames prepared under direction of Carlton B. Downing.

Options for change in military medical care.

"March 1984"--Preface

National medical care utilization and expenditure survey.

Mode of access: Internet.

Medical care and health services for rural people; a study prepared as a result of a conference held at Chicago, Illinois, April 11-13, 1944,

Mode of access: Internet.

Dependents' Medical Care Program; Report

Mode of access: Internet.

Rural health and medical care,

Bibliographical footnotes.

Casework services in public assistance medical care.

First pub. in 1962 by U.S. Bureau of Family Services.

National Medical Care Utilization and Expenditure Survey.

Title from cover.

Carvedilol reduces the costs of medical care in severe heart failure: An economic analysis of the COPERNICUS study applied to the United Kingdom

Background: The aim of this study was to determine the effects of carvedilol on the costs related to the treatment of severe chronic heart failure (CHF). Methods: Costs for the treatment for heart failure within the National Health Service (NHS) in the United Kingdom (UK) were applied to resource utilisation data prospectively collected in all patients randomized into the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study. Unit-specific, per them (hospital bed day) costs were used to calculate expenditures due to hospitalizations. We also included costs of carvedilol treatment, general practitioner surgery/office visits, hospital out-patient clinic visits and nursing home care based on estimates derived from validated patterns of clinical practice in the UK. Results: The estimated cost of carvedilol therapy and related ambulatory care for the 1156 patients assigned to active treatment was 530,771 pound (44.89 pound per patient/month of follow-up). However, patients assigned to carvedilol were hospitalised less often and accumulated fewer and less expensive days of admission. Consequently, the total estimated cost of hospital care was 3.49 pound million in the carvedilol group compared with 4.24 pound million for the 1133 patients in the placebo arm. The cost of post-discharge care was also less in the carvedilol than in the placebo group (479,200 pound vs. 548,300) pound. Overall, the cost per patient treated in the carvedilol group was 3948 pound compared to 4279 pound in the placebo group. This equated to a cost of 385.98 pound vs. 434.18 pound, respectively, per patient/month of follow-up: an 11.1% reduction in health care costs in favour of carvedilol. Conclusions: These findings suggest that not only can carvedilol treatment increase survival and reduce hospital admissions in patients with severe CHF but that it can also cut costs in the process.